Characterization of a murine neuron-enriched model of primary trigeminal ganglia cultures to study the interferon-β antiviral effect against Herpes Simplex Virus type 1  by Low-Calle, Ana Maria et al.
Infectio. 2014;18(2):37--44
Infectio
Asociación Colombiana de Infectología
www.elsevier.es/infectio
ORIGINAL ARTICLE
Characterization  of a  murine  neuron-enriched  model  of  primary
trigeminal ganglia  cultures  to study  the interferon-  antiviral
effect against  Herpes  Simplex  Virus  type  1
Ana Maria Low-Calleb, Jeanette Prada-Arismendyb, Jaime E. Castellanosa,b,∗
a Grupo  de  Patogénesis  Infecciosa,  Facultad  de  Odontología,  Universidad  Nacional  de  Colombia,  Bogotá,  Colombia
b Grupo  de  Virología,  Universidad  El  Bosque,  Bogotá,  Colombia
Received  31  May  2013;  accepted  3  February  2014
Available  online  4  April  2014
KEYWORDS
HSV-1;
Interferon-;
Trigeminal  ganglion;
Neurons;
Neuroﬁlament
Abstract
Objective:  To  characterize  a  neuron-enriched  primary  TG  culture  and  evaluate  interferon-
expression  and  activity  after  HSV-1  infection.
Materials  and  methods:  The  percentage  of  neurons  present  in  cultures  was  assessed  by  neu-
roﬁlament  immunocytochemistry.  Cultures  were  treated  with  interferon-  and  infected  with
HSV-1, then  viral  antigen  positive  cells  were  counted  and  interferon-  expression  was  assessed
by quantitative  PCR.
Results:  The  culture  contained  15%  neurons  and  85%  non-neuronal  cells.  A  cytopathic  effect  was
observed,  associated  with  high  viral  spread  (72.9%  neurons  and  48.3%  non-neuronal  cells  were
positive for  viral  antigen).  Interferon-  treatment  impaired  the  cytopathic  effect  and  decreased
the infected  neurons  to  16.7%  and  infected  non-neuronal  cells  to  7.8%.  Viral  infection  at  6  h  post-
infection signiﬁcantly  increased  the  interferon-  transcripts  by  18.2  fold,  while  at  18  h  post-
infection Interferon  pre-treatment  in  infected  cultures  increased  interferon-  transcription  by
3.7 fold.
Discussion:  This  culture  model  contained  15%  neurons,  which  is  10  times  higher  compared  to
other reported  cultures,  and  non-neuronal  cells  comprised  85%  of  cells  in  this  culture.  All  types
of cells  were  found  to  be  infected,  which  is  similar  to  that  reported  during  acute  infections
in vivo.  Additionally,  interferon-  decreased  the  infected  cells,  avoiding  the  cytopathic  effect,
which is  similar  to  that  reported  in  swine  TG  cultures.
Conclusions:  A  neuron-enriched  primary  TG  model  was  characterized.  Interferon-  treatment
protected  cells  from  cytopathic  effects  and  viral  spread,  while  viral  infection  up-regulatedis  result  means  that  interferon-  exerts  an  important  antiviral  effectinterferon- expression.  Th
against HSV-1  in  these  cultures.
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Caracterización  de  un  modelo  murino  de  cultivos  primarios  de  ganglio  trigeminal
enriquecido  en  neuronas  para  el  estudio  del  efecto  antiviral  del  interferón- frente
al  virus  Herpes  simple  tipo  1
Resumen
Objetivo:  Caracterizar  un  cultivo  primario  de  ganglio  trigeminal  (GT)  enriquecido  en  neuronas
y evaluar  la  expresión  de  interferón-  y  su  actividad  frente  a  la  infección  con  Herpes  simple
tipo 1  (HSV-1).
Materiales  y  métodos: El  porcentaje  de  neuronas  fue  determinado  por  inmunocitoquímica  para
neuroﬁlamento.  Los  cultivos  fueron  tratados  con  interferón-  e  infectados  con  HSV-1,  y  se
cuantiﬁcaron  las  células  positivas  para  antígeno  viral  por  inmunocitoquímica  y  la  expresión  de
interferón- por  PCR  cuantitativa.
Resultados:  El  cultivo  presentó  un  15%  de  neuronas  y  85%  de  células  no  neuronales.  Se  encontró
efecto citopático,  asociado  a  una  alta  diseminación  de  la  infección  (72,9%  neuronas  y  48,3%
de células  no  neuronales  positivas  para  antígeno  viral).  El  interferón-  evitó  la  aparición  de
efecto citopático  y  disminuyó  las  células  infectadas  a  16,7%  en  neuronas  y  a  7,8%  las  células
no neuronales.  La  infección  viral  incrementó  la  expresión  de  transcritos  de  interferón-  18,2
veces a  las  6  h  de  infección,  mientras  que  a  las  18  h  post  infección  el  tratamiento  con  interferón
incrementó  esta  expresión  3,7  veces.
Discusión:  Los  cultivos  presentaron  un  15%  de  neuronas,  lo  cual  es  10  veces  más  que  en  otros
cultivos reportados.  Las  células  no  neuronales  representan  el  85%  de  las  células  del  cultivo,
y se  evidenció  que  todos  los  tipos  de  células  se  infectaron;  similar  a  lo  que  ha  sido  reportado
durante infecciones  agudas  in  vivo.  Adicionalmente,  el  interferón-  disminuyó  el  porcentaje  de
células infectadas  y  evitó  la  aparición  de  efecto  citopático,  similar  a  lo  que  ha  sido  reportado
en cultivos  de  GT  porcino.
Conclusiones:  Se  caracterizó  un  modelo  de  cultivo  primario  de  GT  enriquecido  en  neuronas.
Interferón- protegió  las  células  del  efecto  citopático  y  la  diseminación  viral  mientras  que  la
infección  viral  incrementó  la  expresión  de  interferón-.  Por  lo  tanto,  el  interferón-  ejerció  un
papel antiviral  importante  frente  al  HSV-1  en  estos  cultivos.
© 2013  ACIN.  Publicado  por  Elsevier  España,  S.L.  Todos  los  derechos  reservados.
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uman  Herpes  virus  1  or  HHV-1,  also  known  as  Herpes
implex  virus  type  1  (HSV-1),  is  a  human  pathogen  that
nfects  orofacial  epithelial  cells,  leading  to  cell  death  and
ausing  vesicular  lesions.  This  stage  of  the  viral  replica-
ion  cycle  is  called  lytic  infection.1,2 During  this  cycle,
SV-1  expresses  almost  80  genes  that  regulate  viral  repli-
ation  and  virion  production.  These  viral  particles  are
eleased  from  infected  cells,  spreading  the  infection  in
he  epithelium.1,3 After  replication,  Herpes  virus  is  trans-
orted  by  axonal  transport  to  infect  sensory  neurons  in  the
rigeminal  ganglia  (TG),  where  it  establishes  acute  infec-
ions  characterized  by  viral  replication,  virion  production
nd  further  spreading  infection  in  TG  cells.  This  stage  is
ollowed  by  the  establishment  of  latency,  characterized  by
he  presence  of  the  viral  genome  in  sensory  neurons  with
 very  restricted  gene  expression  proﬁle,  without  repli-
ation  or  virion  production.  Once  this  latent  infection  is
stablished,  the  virus  remains  in  the  TG  for  the  life  of
he  host,  without  cure.  Under  certain  stimuli,  the  virus
eactivates,  triggering  viral  gene  transcription  along  with
ctive  virion  assembly  followed  by  anterograde  transport
f  the  virus  to  the  epithelium,  causing  recurrent  epithelial
esions.4--7
To  control  HSV-1  infections,  it  has  been  identiﬁed  that
he  immune  response  mediated  by  CD8+  lymphocytes  and
a
a
c
tnterferon  gamma  (IFN-) plays  an  important  role  in  the  TG.1
dditionally,  it  has  been  reported  that  endogenous  IFN-
rotects  mice  after  HSV-1  corneal  infections.9 Furthermore,
FN-/ receptor  knockout  mice  are  highly  susceptible
o  HSV-1  infection.10 In  vitro  TG  models  used  to  study
SV-1  infection  have  been  characterized  by  low  percent-
ges  of  neurons,  meaning  they  are  composed  mainly  of
broblasts.11,15 However,  TG  sensory  neurons  are  the  main
nfected  cell  type  in  vivo, and  they  are  responsible  for
atency  establishment  and  reactivation.1 Thus,  the  number
f  neurons  present  in  the  TG  model  plays  a  critical  role  in
aking  it  a  better  approximation  to  the  conditions  observed
n  vivo. It  is  important  to  note  that  in  the  models  previ-
usly  described,  with  low  content  of  neurons,  the  role  of
FN- in  TG  infected  with  HSV-1  is  not  completely  under-
tood.  For  these  reasons,  this  study  aimed  at  establishing
 more  appropriate  in  vitro  TG  model  with  increased  neu-
on  cell  proportions,  to  investigate  HSV-1  infection  stage
n  the  TG,  that  could  allow  a  better  understanding  of  the
G  response  to  the  infection.  To  accomplish  this,  neuron-
nriched  primary  TG  cultures  were  established,  the  neuronal
ells  content  of  this  model  was  characterized  by  neuroﬁla-
ent  immunocytochemistry.  In  addition,  the  role  of  IFN-
gainst  HSV-1  infection  in  TG  was  explored  in  terms  of  the
ssessment  of  changes  in  viral  antigen  positive  cells  and  the
hanges  in  the  expression  of  IFN- transcripts,  after  IFN-
reatment.
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EIn  vitro  effect  of  interferon  beta  on  Herpes  
Materials and methods
Establishment  of  primary  trigeminal  ganglion
cultures
According  to  a  protocol  developed  by  Castellanos  and
Hurtado12 using  mouse  dorsal  root  ganglia,  TG  from  4-week-
old  female  ICR  mice  were  dissected.  Ganglia  were  placed  in
culture  media  composed  of  DMEM  (Sigma),  10%  fetal  bovine
serum  (FBS)  (Gibco)  and  penicillin  100  UI/streptomycin
100  g/ml  (Gibco).  Enzymatic  dissociation  was  performed
with  2  mg/ml  collagenase  (Gibco)  and  5  mg/ml  dispase
(Sigma)  for  1  h  at  37 ◦C,  5%  CO2,  and  95%  humidity.  Mechan-
ical  dissociation  with  a  Pasteur  pipette  was  performed
every  30  min.  The  dissociated  cells  were  centrifuged  at
200  ×  g  for  7  min,  and  the  cell  pellet  was  resuspended  in
culture  medium  with  10%  FBS.  The  cell  suspension  (50  l
per  well)  was  seeded  in  24-well  culture  plates  covered  with
poly-l-lysine  treated  coverslips  (10  g/ml).  Afterwards,  cell
cultures  were  incubated  for  1  h  at  37 ◦C  to  allow  cell  adhe-
sion,  and  volume  was  completed  with  450  l  of  culture
medium  supplemented  with  10  M  -D-Arabinofuranoside
Cytosine  (AraC)  (Sigma).  TG  cultures  were  incubated  for
96  h,  changing  culture  media  every  24  h.  At  the  end  of  96  h,
the  medium  was  replaced  with  AraC-free  culture  medium,
and  cultures  were  incubated  for  another  24  h  before  viral
infection.
Interferon- pre-treatment  and  Herpes  Simplex
Virus type  1  infection  of  trigeminal  ganglion
cultures
Virus  from  a  clinical  case  of  herpes  labialis  was  isolated  and
harvested  in  the  Vero  cell  line.  After  5  days  of  incubation,
cells  were  freeze-thawed,  and  supernatants  were  clariﬁed
(10,000  ×  g  10  min).  Supernatant  aliquots  were  stored  at
−70 ◦C.  HSV-1  in  supernatants  was  then  titered  by  plaque
assay  in  Vero  cells  (titer  was  1  ×  107 UFP/ml).  HSV-1  was
conﬁrmed  based  on  the  PCR  protocol  developed  by  Kessler
et  al.13 After  a  96  h  incubation  with  AraC  supplemented
media  and  an  18  h  incubation  in  AraC-free  culture  media,
TG  cultures  were  treated  with  1000  U/ml  of  murine  IFN-
recombinant  protein  (PBL  12400-1)  or  culture  media  alone
for  6  h  before  infection.  After  the  incubation  period,  the
medium  was  washed  out,  and  the  cultures  were  infected
with  mock  (Vero  cell  lysate)  or  HSV-1  at  a  multiplicity  of
Infection  (MOI)  of  1,  in  5%  FBS  supplemented  culture  media.
One  hour  post-infection,  the  inoculum  or  mock  was  removed
and  replaced  with  fresh  10%  FBS  supplemented  culture
media.  Finally,  the  TG  cultures  were  incubated  for  addi-
tional  28  h  for  immunocytochemistry  assays,  and  for  6,  12
and  18  h  for  quantitative  PCR  experiments.
Characterization  of  the  trigeminal  ganglion
cultures  with  Immunoperoxidase  assay  for
Neuroﬁlament  and  Herpes  Simplex  Virus  type  1
antigen
Infected  TG  cultures  were  ﬁxed  in  4%  paraformaldehyde
(Carlo  Erba),  and  monolayers  were  treated  with  0.5%  gelatin
T
B
i39
Sigma)  to  prevent  cell  detachment  from  the  coverslips.
fterwards,  monolayers  were  treated  with  0.1%  Triton  X-
00  (Sigma)  for  30  min  and  endogenous  peroxidases  were
nactivated  with  0.5%  hydrogen  peroxide  in  50%  methanol
or  45  min.  Subsequently,  blocking  was  performed  with  10%
BS  for  30  min,  followed  by  incubation  either  with  mono-
lonal  antibody  against  the  speciﬁc  neuronal  intermediate
lament  (neuroﬁlament)  (Sigma  A-5316)  diluted  1:2000  in
%  SFB  for  1  h  at  room  temperature,  or  rabbit  anti-HSV-
 (Dako  B0114)  diluted  1:40  with  5%  SFB  for  16  h  at  4 ◦C.
ext,  biotinylated  anti-rabbit  (Vector  BA-1000)  or  biotiny-
ated  anti-mouse  (Vector  BA-9200)  secondary  antibody  were
dded  at  a  1:200  dilution  for  30  min  at  room  temperature.
hen,  1  g/ml  streptavidin-peroxidase  (Vector  SA-5001)  was
dded  and  incubated  for  30  min.  Finally,  0.5%  hydrogen
eroxide  with  0.1%  Diaminobenzidine  (MP  Biomedicals)  in
ris--HCl  pH  7.2  (Sigma)  were  added  for  staining.  Two  inde-
endent  cultures  with  three  replicas  each  were  evaluated
or  immunoperoxidase-positive  staining.
NA  extraction,  reverse  transcription  and
eal-time PCR  for  interferon-  expression
otal  RNA  was  isolated  from  TG  cultures  using  Trizol  Reagent
Invitrogen)  following  the  manufacturer’s  instructions.  RNA
as  solubilized  in  0.1%  v/v  Diethyl  pyrocarbonate-treated
ater.  Isolated  RNA  was  quantiﬁed  by  A260nm  (Nanodrop
D1000,  ThermoScientiﬁc)  and  then  treated  with  DNAse  I
Sigma),  and  cDNA  was  synthesized  from  500  ng  of  RNA  per
ample  using  random  primers  and  250  U  of  MMLV  (Promega).
elative  expression  was  then  quantiﬁed  using  the  DyNAmo
S  SYBR  Green  quantitative  PCR  kit  (Finnzymes)  in  a  real-
ime  thermocycler  (CFX96  Biorad).  The  PCR  program  was
s  follows:  10  min  initial  denaturation  at  95 ◦C  followed  by
0  cycles  of  95 ◦C  for  30  s  and  57 ◦C  for  1  min  for  IFN- and
0 ◦C  for  1  min  for  -actin.  Product  speciﬁcity  was  veriﬁed
ith  a  dissociation  curve  created  by  reading  the  ﬂuores-
ence  between  100 ◦C  and  60 ◦C.  The  following  primers
esigned  in  our  group  were  used:  Actin-F:  ATC  CTC  TTC
TC  CCT  GGA  GA,  Actin-R:  TGC  CTG  GGT  ACA  TGG  TGG
A,  IFNB-F:  GCA  GCT  GAA  TGG  AAA  GAT  CA;  IFNB-R:
GG  CAA  AGG  CAG  TGT  AAC  TC.  -Actin  mRNA  was  used  as
 housekeeping  normalizer  gene.  Relative  gene  expression
as  quantiﬁed  by  comparing  gene  expression  levels  from
irus-infected  cultures  against  mock-infected  cultures.
elative  expression  of  IFN- gene  was  calculated  using  the
athematical  method  described  by  Schefe  et  al.14 Two
ndependent  experiments  were  performed.
tatistics
PSS  V14  statistical  analysis  software  was  used  to  perform
ann--Whitney  test  to  determine  signiﬁcant  differences
p  <  0.05).
thicshis  research  project  was  approved  by  the  Universidad  El
osque  Ethics’  Committee  and  it  was  performed  under  eth-
cal  regulations  according  to  Colombian  Health  Ministry’s
4 A.M.  Low-Calle  et  al.
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Figure  1  TG  primary  culture  processed  by  immunocytochem-
istry for  neuroﬁlament  protein  detection  as  marker  of  neuronal
cells.  a.  Panoramic  view  of  neuroﬁlament  positive  cells  (bar
represents  200  m).  b.  Photomicrograph  of  neuroﬁlament  pos-
itive neurons.  Note  the  round  somas  and  the  immunoreactive
neurites  (scale  bar  represents  40  m).  c.  Aspect  of  a  TG  culture0  
esolution  8430  of  1993.  In  addition,  the  research  was  per-
ormed  taking  into  account  the  Universal  declaration  of
nimal  rights  from  the  International  League  of  Animal  Rights
Law  84  of  1989,  Geneva,  Switzerland)  and  according  to  ethi-
al  animal  research  principles  from  the  International  Council
or  Laboratory  Animals.
esults
haracterization  of  primary  trigeminal  ganglion
ultures in  terms  of  neuronal  and  non-neuronal
ells content
G  cultures  were  incubated  for  96  h  with  AraC-
upplemented  medium.  The  medium  was  then  replaced
ith  fresh  AraC-free  culture  medium,  and  cultures  were
ncubated  for  another  24  h.  Cultures  were  ﬁxed  and  stained
sing  an  immunoperoxidase  assay  for  neuroﬁlament  to
haracterize  their  neuronal  and  non-neuronal  cell  content.
fter  120  h  of  incubation,  there  were  11,000  cells  per  TG
ulture  consisting  of  14.7  ±  2.8%  of  neurons  and  85.3  ±  2.8%
on-neuronal  cells.  Thus,  a  TG  culture  model  was  obtained,
haracterized  by  the  presence  of  a  neurite  network  that
overed  the  coverslip  surface  (Fig.  1a  and  b).
he  interferon- treatment  protected  the
rigeminal ganglion  cells  from  Herpes  Simplex  Virus
ype 1 infection  and  cytopathic  effect
 cytopathic  effect  was  observed  in  TG  cells  infected  with
SV-1  after  28  h.  This  effect  was  characterized  by  the  loss  of
hape,  cell  rounding  and  the  loss  of  birefringence  in  infected
on-neuronal  cells  (Fig.  2c).  However,  IFN- pre-treated
nfected  cultures  did  not  show  any  signs  of  this  cytopathic
ffect  (Fig.  2d),  and  the  cellular  morphology  of  the  IFN-
reated  infected  cultures  was  similar  to  uninfected  cultures
Fig.  2a  and  b).  This  ﬁnding  suggests  that  IFN- impaired  the
nset  of  cytopathic  effect  after  HSV-1  infection.
After  28  h  of  infection  by  HSV-1,  the  cultures  were
xed  and  processed  for  immunocytochemistry  to  detect
iral  antigen  and  obtain  infected  cell  percentages.  In  TG
ultures  infected  for  28  h,  a  more  disseminated  HSV-1  infec-
ion  (Fig.  3a)  was  evidenced,  with  72.9%  of  neuronal  cells
nd  48.3%  of  non-neuronal  cells  positive  for  viral  antigen
Fig.  3d).  However,  pre-treatment  with  1000  U/ml  of  IFN-
igniﬁcantly  decreased  (Mann--Whitney  p  <  0.05)  the  number
f  positive  viral  antigen  cells  to  16.7%  of  neuronal  and  7.8%
f  non-neuronal  cells  (Fig.  3d).  Moreover,  IFN- reduced
he  viral  infection  to  small  isolated  groups  of  infected  cells
Fig.  3b).  These  results  indicate  that  IFN- treatment  had  an
ntiviral  effect  that  decreased  the  percentages  of  neuronal
nd  non-neuronal  infected  cells  and  impaired  virus  spread
n  the  TG  cultures.
erpes  Simplex  Virus  type  1  infection  signiﬁcantly
ncreased the  expression  of  interferon-  mRNA  in
rigeminal  ganglion  cells
FN- mRNA  was  quantiﬁed  by  quantitative  PCR  in  TG  cul-
ures  infected  for  6,  12  and  18  h  with  HSV-1,  and  in  cultures
processed  lacking  the  neuroﬁlament  primary  antibody,  as  neg-
ative control.  Scale  bar  represents  200  m.
In  vitro  effect  of  interferon  beta  on  Herpes  41
Figure  2  IFN-  protects  TG  cultured  cells  from  cytopathic  effect  caused  by  HSV-1  infection.  a.  Phase  contrast  micrographs  of  TG
cultures treated  for  6  h  with  1000  U/ml  of  IFN-  before  HSV-1  infection.  b.  IFN-  untreated  and  mock  infected  TG  culture.  c.  IFN-
untreated and  HSV-1  infected  TG  culture.  d.  TG  cultures  treated  with  IFN-  and  infected  with  HSV-1.  Note  the  round  and  refringent
morphology of  neurons  (*)  and  the  morphology  of  ﬁbroblasts  and  Schwann  cells  (arrows).  The  virus  induced  cytopathic  effect  can
be seen  in  both  types  of  cells  (arrow  heads).  Scale  bar  represents  40  m.  Figure  representative  of  two  independent  experiments
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pre-treated  with  IFN- and  then  infected.  Relative  expres-
sion  of  IFN- gene  was  calculated  using  the  mathematical
method  described  by  Schefe  et  al.14 It  was  evidenced  that
HSV-1  infection  signiﬁcantly  increased  IFN- transcription  in
TG  cultures  by  18.2  fold  at  6  h.p.i  (Mann--Whitney  p  < 0.05),
compared  to  HSV-1  infected  cultures.  In  contrast,  in  IFN-
pre-treated  and  infected  cultures,  IFN- expression  was
signiﬁcantly  up-regulated  3.7  fold  compared  to  infected
untreated  cultures  (Mann--Whitney  p  <  0.05).  This  means
that  HSV-1  infection  triggers  IFN- mRNA  expression  in
early  infection  of  TG  primary  cultures,  and  IFN  treatment
before  infection  induces  IFN- expression  at  later  stages  of
infection  (Fig.  3e).
Discussion
A  neuron  enriched  primary  trigeminal  ganglion
culture model  susceptible  to  Herpes  Simplex  Virus
type 1 infection  was  established
HSV-1  is  a  neurotropic  virus  frequently  studied  in  both  in  vivo
and  in  vitro  models.  The  in  vitro  model  described  by  Carr
et  al.11 is  a  TG  primary  culture  with  just  1.5%  neuronal
cells  and  a  high  percentage  of  non-neuronal  cells,  mainly
ﬁbroblasts.11 Such  a  low  percentage  of  neurons  makes  dif-
ﬁcult  the  interpretation  of  the  results,  because  sensory
neurons  are  the  main  group  of  cells  infected  in  vivo  and  are
responsible  for  latency  establishment  and  reactivations.1
The  model  described  in  this  work  has  a higher  percent-
age  of  sensory  neurons,  compared  to  previously  reported
i
n
a
iultures,11 which  could  represent  a  better  in  vitro  approxi-
ation  of  what  may  occur  in  TG  cells  after  HSV-1  infection,
ecause  the  TG  sensory  neurons  are  the  main  cell  type
nfected  in  vivo, and  they  are  responsible  for  latency  estab-
ishment  and  reactivation.1
In  the  model  described  here,  the  sensory  neurons  estab-
ish  a  neurite  network  covering  most  of  the  dish  surface
Fig.  1a),  which  most  likely  increases  the  interactions
etween  HSV-1  and  neurons.  In  spite  of  being  the  smallest
ercentage  of  cells  in  culture,  neurons  represent  the  highest
ercentage  of  infected  cells  (72.9%)  (Fig.  3d),  reﬂecting  the
eurotropism  of  HSV-1.  However,  in  these  in  vitro  circum-
tances,  the  entire  neuronal  cell  body  and  neurite  network
re  available  for  infection,  which  could  explain  this  high  pro-
ortion  of  neuronal  cells  infected.  This  contrasts  with  the
n  vivo  infection,  where  virions  must  enter  the  sensory  nerve
ndings  at  the  epithelium  and  travel  along  the  axons  to  the
ell  body  to  establish  infections.  Evidently,  this  condition
epresents  a  limitation  of  the  model.
On  the  other  hand,  the  fact  that  ﬁbroblasts  and  Schwann
ells  are  the  vast  majority  of  cells  in  the  culture,  means
hat  they  may  account  for  the  most  part  of  the  response
bserved,  but  we  cannot  establish  which  type  of  cell  is
esponsible  for  the  observed  results,  since  all  types  of  cells
et  infected  (Fig.  3a  and  d).  This  infection  of  non-neuronal
ells,  has  also  been  reported  during  acute  infection  periods
n  mouse  models  in  vivo.15 Therefore,  we  believe  our  model
s  valuable  even  though  the  vast  majority  of  cells  are  non-
euronal  type,  because  here  we  show  that  IFN- induced
 response  that  controlled  the  viral  infection  dissemination,
mpaired  the  viral  induced  cell  death  and  decreased  the  viral
42  A.M.  Low-Calle  et  al.
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Figure  3  IFN-  treatment  impaired  viral  spreading  and  decreased  infected  TG  cell  percentage.  a.  Micrograph  of  immunoperoxidase
staining showing  viral  antigen  detection  in  IFN-  untreated  and  HSV-1  infected  TG  cultures.  Inset  higher  magniﬁcation  of  cultures.
b. Aspect  of  IFN-  pre-treated  and  HSV-1  infected  cultures.  Note  the  reduction  of  virus  immunopositive  cells.  Inset  higher  magni-
ﬁcation of  cultures.  c.  Control  culture  processed  lacking  the  anti-HSV-1  primary  antibody.  Scale  bar  represents  200  m.  Inset  scale
bar represents  40  m  d.  Viral  antigen  positive  cell  percentages  in  IFN-  treated  and  untreated  cultures.  (*)  Represents  p  <  0.05  of
Mann--Whitney  test  between  HSV-1  infected  TG  cultures  compared  to  Interferon-  treated  and  HSV-1  infected  cultures  e.  IFN-
mRNA relative  expression  in  TG  cultures  infected  with  HSV-1  for  6,  12  and  18  h.p.i.  and  in  cultures  pre-treated  with  IFN-  and
infected with  HSV-1.  Bar  represents  mean  ±  Standard  error  of  the  mean  of  2  independent  experiments  performed  by  duplicate.  (*)
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nepresents p  <  0.05  of  Mann--Whitney  test  between  HSV-1  infect
G cultures.
ntigen  expression  in  TG  cells  during  a  productive  infection,
nd  it  might  suggest  an  important  role  of  non-neuronal  cells
uring  acute  infections.
Additionally,  HSV-1  infection  was  evidenced  at  28  h  post
nfection  by  cytopathic  effect  (Fig.  2c)  and  the  presence  of
igh  number  of  infected  cells  (Fig.  3a).  This  suggests  that
SV-1  replicates  through  a  lytic  cycle  leading  to  cell  death,
s  previously  shown  in  swine  TG  culture  models  infected
ith  HSV-1.16 Moreover,  in  our  model,  the  highly  spread
nfection  observed  in  all  kinds  of  TG  cells,  is  consistent  with
m
i
a
ttreated  TG  cultures  compared  to  HSV-1  infected  IFN-  treated
he  acute  infection  stage  in  TG  of  a  mouse  model  infected
n  vivo.15 Where  HSV  positive  staining  was  observed  in  TG
eurons,  surrounding  satellite  cells,  as  well  as  in  Schwann
ells  and  ﬁbroblasts  beginning  at  2  days  p.i  with  maxi-
al  expression  at  3  days  p.i.15 These  mean  that  we  did
ot  establish  a  latency  model  of  infection  but  an  in  vitro
odel  of  acute  or  productive  infection.  This  could  provide
nformation  regarding  the  response  of  TG  cells,  neuronal
nd  non-neuronal,  against  the  active  herpetic  infection
hat  occurs  previous  to  the  latency  establishment  or  after
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RIn  vitro  effect  of  interferon  beta  on  Herpes  
reactivation  periods,  in  which  the  role  of  non-neuronal  cells
to  control  HSV  infections  remains  unclear.
Antiviral  effect  of  interferon  against  Herpes
Simplex Virus  type  1  in  trigeminal  ganglion  cultures
IFN- treatment  signiﬁcantly  decreased  the  numbers  of  neu-
ronal  and  non-neuronal  infected  cells.  This  result  implies
that  TG  cells  in  culture,  including  neurons,  have  the  abil-
ity  to  respond  to  exogenous  IFN- stimulation,  activating  an
antiviral  state  to  control  HSV-1  infection.  This  property  has
been  reported  in  different  neuronal  cell  types  such  as  pri-
mary  murine  cortical  neurons,  which  express  antiviral  genes
such  as  Protein  kinase  R  after  IFN- treatment,17 and  pri-
mary  murine  cerebellar  neurons,  which  increase  expression
of  the  antiviral  gene  Oligoadenylate  synthetase  after  IFN-
treatment.18 On  the  other  hand,  in  a  swine  TG  culture  model
infected  with  HSV-1,  the  cytopathic  effect  was  impaired,
and  viral  antigen  expression  was  decreased  after  IFN-
treatment16 and  it  was  also  observed  in  our  model.  Further-
more,  in  vivo  models  have  suggested  a  protective  effect
of  IFN-I  (which  includes  the  IFN- and  IFN-) in  acute
HSV-1  infections  in  TG,  increasing  mouse  survival  against
infection.19--22 Additional  studies  have  conﬁrmed  that  in  vivo
HSV-1  replication  increases  in  TG  after  neutralization  of  IFN-I
with  an  injection  of  IFN-I  antibody  or  when  the  IFN-I  receptor
gene  is  deleted  in  knockout  mice.10,23
Moreover,  there  is  evidence  suggesting  that  mouse  TG
infected  with  HSV-1  produce  IFN- and  -  at  6  days  post-
infection  in  vivo,7,8 but  there  was  no  evidence  that  this
could  also  happen  in  vitro. In  our  model  IFN- mRNA  was  up-
regulated  early  in  HSV-1  infection  of  TG  cultures  (Fig.  3e),
which  represents  the  ﬁrst  in  vitro  TG  model  in  which  this
was  found,  because,  a  previous  report  of  in  a  TG  in  vitro
model  with  low  percentage  of  neuronal  cells,11 it  was  found
no  evidence  of  IFN  production  after  HSV-1  infection.11 How-
ever,  in  our  neuron  enriched  culture  model,  we  found  that
the  TG  cells  activate  an  innate  antiviral  response  against
viral  infection,  which  increased  IFN- transcription,  sug-
gesting  that  our  model  could  be  a  better  in  vitro  approach
than  previously  reported  TG  cultures.  In  addition,  our  group
previously  reported  that  after  12  h  of  HSV-1  infection,
the  IFN  induced  antiviral  genes  2′--5′ oligoadenylate  syn-
thetase  and  latent  ribonuclease  were  up-regulated.24 Since,
it  has  been  described  that  these  genes  are  transcriptio-
nally  induced  after  IFN- activates  its  cellular  receptor
and  induces  the  Jak--Stat  signalling,25 we  believe  that  the
increased  transcription  of  those  antiviral  genes,  in  infected
TG  cultures,  was  due  to  the  increased  transcription  (and
possibly  increased  production)  of  IFN- that  we  found  here,
triggered  by  HSV  infection.  In  addition,  we  evidenced  here,
that  in  virus  infected  and  IFN- treated  cultures,  a  late
IFN-  transcription  occurred,  that  we  speculate  could  be
explained  as  a  consequence  of  the  autocrine  effect  induced
by  the  IFN- treatment,  which  transcriptionally  triggers  its
own  expression.
On  the  other  hand,  since  the  majority  of  cells  in  our
model  are  non-neuronal  type,  it  is  possible  that  they  are  the
main  responsible  for  this  IFN  expression  but,  at  the  same
time  as  most  neuronal  cells  are  also  infected,  their  pos-
sible  role  as  IFN- producers  in  this  system  could  not  be43
xcluded  entirely.  The  results  obtained  in  this  study  and
hose  mentioned  above,  suggest  that  the  IFN- produced
fter  infection  could  play  an  important  antiviral  role  that
ontrols  acute  HSV-1  infections  and  prevents  virus  spread  in
G  in  vivo  as  well  as  in  vitro.
In  conclusion,  the  novel  neuron-enriched  TG  primary
ulture  model  described  here  was  highly  susceptible  to  HSV-
 productive  infection  that  leads  to  cytopathic  effect.
Additionally,  we  can  conclude  that  IFN- exerts  an
mportant  antiviral  effect  against  HSV-1,  causing  inhibition
f  the  cytopathic  effect,  decreased  viral  antigen  expres-
ion  and  impaired  spread  of  the  infection  in  monolayers.
s  a consequence,  IFN- protected  both  neuronal  and
on-neuronal  cells  from  HSV-1  infection.  But  we  can
onclude  that  our  neuron-enriched  culture  model  could
e  a  better  approximation  to  study  HSV  acute  stages  of
erpes  infection,  compared  to  other  primary  TG  cultures
reviously  described  with  low  neuron  cells  percentages.
his  characteristic  makes  it  a  valuable  model  for  further
tudies  that  may  elucidate  the  mechanisms  behind  the
cute  stages  of  HSV-1  infection  in  the  TG,  previous  to
atency  establishment  or  even  after  the  reactivation  stages.
his  could  lead  to  a  better  understanding  of  the  molecular
nd  cellular  aspects  of  TG  viral  infection.  Besides,  it  could
elp  develop  or  evaluate  putative  antiviral  treatments,  or
ven  establish  further  in  vitro  latency  models.
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